Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Multiple Sclerosis
 More »

  • Antisense Drugs Finally Turning the Corner
    ... antisense drug to VLA-4, has shown "outstanding activity in Phase II studies potently reducing new active brain lesions in multiple sclerosis patients," explained Diamond. ...
    10-15-2013
  • Teva Cutting 5,000 Jobs in Global Restructuring
    Next year, sales of its flagship branded injection drug, Copaxone for multiple sclerosis, are expected to start slipping due to newer oral versions of the drug as well as expected ...
    10-10-2013
  • J&J's Janssen Companies Launch a Trio of Collaborations
    FR104 is the subject of numerous ongoing preclinical studies across autoimmune disease models that include models of rheumatoid arthritis, multiple sclerosis, and psoriasis. FR104 ...
    10-3-2013
  • First Direct Measurement of Spinal Cord Myelin in MS
    Scientists at the Case Western Reserve University School of Medicine have developed a new imaging tool to examine myelin damage caused by multiple sclerosis (MS). They believe ...
    9-24-2013
  • Genzyme's MS Drug Lemtrada Receives EU Authorization
    Genzyme said today it won marketing authorization from the European Union for its multiple sclerosis (MS) drug Lemtrada(tm) (alemtuzumab). The authorization represents the drug's ...
    9-17-2013
  • As Big Deals Resurface, Who's Next to the Altar?
    ... Acorda has had sales success and plans to add indications to its multiple sclerosis drug Ampyra; Ariad's leukemia drug Iclusig has been projected to reach $2.5 billion in annual ...
    9-9-2013
  • Karo Wins First Milestone for Autoimmune Disease Deal with Pfizer
    to Karo, the nuclear hormone receptor RORgamma is an attractive target for the treatment of autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and psoriasis. ...
    9-5-2013
  • Boosting Your Brain Power with Sleep
    Cirelli speculated the findings suggest that extreme and/or chronic sleep loss could possibly aggravate some symptoms of multiple sclerosis (MS). He noted that future experiments ...
    9-4-2013
  • Myelin Repair Foundation, Gencia Partner to Speed Up MS Drug...
    the myelin regenerating capabilities of the company's therapeutic compounds for multiple sclerosis (MS), with the goal of advancing myelin repair therapeutic development for MS. ...
    8-14-2013
  • Pluristem Wins $3.3M Israeli Grant to Advance Pipeline
    and muscle damage when administered locally, and in inflammatory bowel disease, multiple sclerosis, and stroke when administered systemically. Company plans to move new ...
    8-6-2013
  • What Junk DNA? It's an Operating System
    ... and the de novo identification of pathogenic cell types for Crohn's disease, multiple sclerosis, and an electrocardiogram trait without prior knowledge of physiological mechanisms. ...
    8-6-2013
  • Improving Preclinical Research
    ... studying conditions like Alzheimer's disease and amyotrophic lateral sclerosis. ... To do so, he notes, will require the involvement of multiple stakeholders. Researchers ...
    7-29-2013
  • Perrigo Buying Elan for $8.6B
    biotech into a combined company with double-digit royalty income from the multiple sclerosis (MS) blockbuster treatment Tysabri® (natalizumab) and Ireland's low corporate taxes. ...
    7-29-2013
  • Adimab Licenses Antibody Platform to GSK, Biogen Idec
    with Biogen Idec by licensing to the biotech giant its antibody platform for use in Biogen Idec's targeted therapeutic areas, which include multiple sclerosis and hemophilia. ...
    7-26-2013
  • Biogen Idec, University of Edinburgh Team Up for Neurodegenerative...
    Biogen Idec and the University of Edinburgh have agreed to a three-year collaboration in which they plan to study multiple sclerosis (MS) and motor neuron disease, then identify ...
    7-19-2013
  • More »

    Journal Articles

  • Multiple Sclerosis and Hepatitis C Virus Infection Are Associated...
    Giuliana Fortunato, Giuseppe Calcagno, Vincenzo Bresciamorra, Elena Salvatore, Alessandro Filla, Silvana Capone, Rosario Liguori, Salvatore Borelli, Ivan Gentile, Francesco Borrelli, Guglielmo Borgia, Lucia Sacchetti
    Journal of Interferon & Cytokine Research
    Multiple Sclerosis and Hepatitis C Virus Infection Are Associated with Single Nucleotide Polymorphisms in Interferon Pathway Genes Journal of Interferon & Cytokine Research ...
  • Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities
    Djordje Miljkovic, Ivan Spasojevic
    Antioxidants & Redox Signaling
    Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities Antioxidants & Redox Signaling The pathophysiology of multiple sclerosis (MS) involves several components: ...
  • Studies of Multiple Sclerosis in Communities Concerned about...
    Dhelia M. Williamson
    Journal of Women's Health
    Studies of Multiple Sclerosis in Communities Concerned about Environmental Exposures Journal of Women's Health Multiple sclerosis (MS) is an autoimmune disease that differentially ...
  • Viruses and Multiple Sclerosis
    Claudio Cermelli, Steven Jacobson
    Viral Immunology
    Viruses and Multiple Sclerosis Viral Immunology Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system whose cause is still unknown. Many findings ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll